)
)
Making Medicine From The Microbiome
-
The human gut microbiome composition influences clinical response to cancer immunotherapy
-
Microbiotica identified and cultured key bacterial species associated with positive clinical response to immunotherapy in melanoma patients
-
Key bacterial species trigger different immunological responses underpinning cancer immunotherapy in patients
-
Microbiotica manufactured a 9-strain live biotherapeutic product for oral delivery, named MB097, with multi-functional therapeutic effects
-
Microbiotica completed recruitment of the Melody study testing MB097 is melanoma patients (https://clinicaltrials.gov/study/NCT06540391)
